Investigational Agent Reduces Disease Activity In Multiple Sclerosis
eMaxHealth.com - Hickory,NC,USA
... it is not approved for use in multiple sclerosis. Rituximab has been associated with fatal infusion reactions, tumor lysis syndrome, ...
See all stories on this topic

May -- Multiple Sclerosis Awareness Month -- latest research is ...
EurekAlert (press release) - Washington,DC,USA
Montreal, QC -- May is Multiple Sclerosis Month and there is no better way of raising awareness for this unpredictable and often debilitating disease then ...
See all stories on this topic

Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple
WebWire (press release) - Atlanta,GA,USA
... study of Rituxan® (rituximab) in patients with relapsing-remitting multiple sclerosis (RRMS) were presented today at the American Academy of Neurology ...
See all stories on this topic